therapies 'not used enough' in patients with type 2 diabetes and cardiovascular risk
Published 2 years ago • 255 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
34:19
improving recognition of heart failure in patients with type 2 diabetes: prognostic implications ...
-
1:33:15
navigating the nexus of t2d and cvd: moving beyond glucose management.
-
4:18
cardiovascular risk stratification in patients with type 2 diabetes
-
14:56
is diabetes a cardiovascular risk equivalent?
-
16:41
zooming in on cardiovascular risk control with glucagon-like peptide-1 receptor agonists in diabetes
-
1:13:38
approaches to reducing cvd risk in type 2 diabetes
-
4:33
does bariatric surgery reduce cardiovascular disease in patients with type 2 diabetes?
-
54:55
cerebral microvascular pathology: a common endophenotype between tbi, cvd and dementia?
-
21:32
a patient with type 2 diabetes and chronic kidney disease in clinical practice
-
27:22
10 things people with diabetes need to know about heart health
-
21:33
cardiometabolic risk control in diabetes: latest insights and recommendations
-
9:08
time to act: understanding your cardiovascular risk as a patient with type 2 diabetes
-
9:31
what patients with diabetes should know about cardiovascular risk
-
2:09
cardiovascular outcomes in patients with diabetes
-
29:41
cardioprevention and diabetes: assessing the role of aspirin and antiplatelets
-
22:56
diabetes trials: challenges and current directions
-
32:35
reducing cardiovascular risk in diabetes
-
27:18
diabetologist’s perspective of diabetes and cardiovascular risk management in post-acs t2d patients
-
1:05:26
ask the experts: type 2 diabetes and cvd risk